-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UHd3HXWz6utfnD6Fgi+bZZfkzVSWYAwz7gzMwZjD4E/xK+XLv7R9Tal81TGNDZwZ PZJ1zwMwWrpkgm5ifW2vlQ== 0001193125-05-215306.txt : 20051103 0001193125-05-215306.hdr.sgml : 20051103 20051103121744 ACCESSION NUMBER: 0001193125-05-215306 CONFORMED SUBMISSION TYPE: S-8 POS PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20051103 DATE AS OF CHANGE: 20051103 EFFECTIVENESS DATE: 20051103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SYNBIOTICS CORP CENTRAL INDEX KEY: 0000719483 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 953737816 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 POS SEC ACT: 1933 Act SEC FILE NUMBER: 333-119769 FILM NUMBER: 051175911 BUSINESS ADDRESS: STREET 1: 11011 VIA FRONTERA CITY: SAN DIEGO STATE: CA ZIP: 92127 BUSINESS PHONE: 8584513771 MAIL ADDRESS: STREET 1: 11011 VIA FRONTERA CITY: SAN DIEGO STATE: CA ZIP: 92127 S-8 POS 1 ds8pos.htm POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Post-Effective Amendment No. 1 to Form S-8

As filed with the Securities and Exchange Commission on November 3, 2005

Registration No. 333-119769

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

SYNBIOTICS CORPORATION

(Exact name of registrant as specified in its charter)

 

 

California   95-3737816

(State or other jurisdiction

incorporation or organization)

  

(IRS Employer of

Identification No.)

11011 Via Frontera

San Diego, California

   92127
(Address of principal executive offices)   (Zip Code)

 

 

2004 STOCK OPTION/STOCK ISSUANCE PLAN

(Full title of the plan)

 

 

KEITH A. BUTLER

VICE PRESIDENT - FINANCE AND CHIEF OPERATING OFFICER

SYNBIOTICS CORPORATION

11011 VIA FRONTERA, SAN DIEGO, CALIFORNIA 92127

(Name and address of agent for service)

 

(858) 451-3771

(Telephone number, including area code, of agent for service)

 

 

With Copies To:

 

Hayden J. Trubitt, Esq.

Heller Ehrman LLP

4350 La Jolla Village Drive

7th Floor

San Diego, CA 92122

 

 

This Registration Statement shall become effective immediately upon filing with the Securities and Exchange Commission, and sales of the registered securities will thereafter be effected upon option exercises effected and/or stock issuances made under the 2004 Stock Option/Stock Issuance Plan.

 

SYNBIOTICS CORPORATION

 

Deregistration

 

This registration statement registered 3,000,000 shares of the Common Stock of Synbiotics Corporation (the “Company”). These shares were offered pursuant to the Company’s 2004 Stock Option/Stock Issuance Plan, as amended (the “Option Plan”). No shares have been issued under the Option Plan. The Company is “going private” and is terminating the registration of its Common Stock under Rule 12g-(4)(a)(1)(i) of the Securities Exchange Act of 1934, as amended. Accordingly, the Company hereby deregisters 3,000,000 shares of the Common Stock originally covered by the registration statement.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on November 3, 2005.

 

SYNBIOTICS CORPORATION

By:   

  

/s/ Keith A. Butler

   

Keith A. Butler

   

Vice President – Finance and Chief Financial Officer

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

SIGNATURE

   

TITLE

  

DATE

/s/ Paul R. Hays

   

Chief Executive Officer, President and Director

(Principal Executive Officer)

  

November 3, 2005

Paul R. Hays

       

/s/ Keith A. Butler

   

Chief Financial Officer (Principal Financial

Officer and Principal Accounting Officer)

  

November 3, 2005

Keith A. Butler

       

/s/ Thomas A. Donelan

   

Director

  

November 3, 2005

Thomas A. Donelan

       

/s/ Christopher P. Hendy

   

Director

  

November 3, 2005

Christopher P. Hendy

       

 

-1-

-----END PRIVACY-ENHANCED MESSAGE-----